cancer signalling and stem cell intro
Cancer Signaling Pathways Overview
Recap of Key Aspects from Previous Studies
This section emphasizes the review of the foundational concepts covering signal transduction in normal and diseased states, particularly focusing on cancer. Key concepts are connected to the processes of transcription and translation from genetics and molecular biology modules undertaken in prior courses.
Signaling in Normal Cells
Understanding normal signaling mechanisms in cells is crucial for comprehending disease states.
Normal cellular communication primarily involves signals that either promote cell proliferation, maintain quiescence, or induce differentiation.
Molecular Drivers of Cancer
Tumor suppressor genes and oncogenes play pivotal roles as the primary molecular drivers of cancer.
An understanding of the associated pathways for these genes can shed light on cancer development and progression.
Introduction to the Central Dogma of Molecular Biology
The central dogma describes the flow of genetic information from DNA to RNA to protein but has evolved:
Traditional view: Unidirectional flow from DNA to RNA to proteins.
Current perspective: Dynamic interactions between DNA and various types of RNA, including microRNAs, influence gene expression.
Transcription and Translation Processes
Transcription: The process involves producing messenger RNA (mRNA) from DNA sequences.
Transcription occurs in three stages:
Initiation: Assembly of transcription factors and RNA polymerase on the promoter region.
Elongation: RNA polymerase synthesizes RNA by adding nucleotides complementary to the DNA template.
Termination: RNA polymerase concludes transcription when it recognizes termination signals.
Translation: The synthesis of proteins from mRNA at ribosomes through:
Initiation: The assembly of ribosomal subunits at the start codon (AUG).
Elongation: Sequential addition of amino acids, reading codons in groups of three.
Termination: The process ends when a stop codon is reached (UAA, UAG, UGA), releasing the polypeptide chain.
Genetic Code and Codons
Codons are triplet sequences of nucleotides that correspond to specific amino acids, determining protein synthesis.
Start codon: AUG (Methionine), and stop codons: UAA, UAG, UGA regulate the protein synthesis process.
Gene Regulation Mechanisms
The regulation of gene expression is vital to cellular function and integrity, with several control points:
Transcriptional Control: Modulation of transcription initiation through promoter and transcription factors (e.g., TFIID, TFIIA, TFIIB, etc.).
Post-transcriptional Modifications: mRNA undergoes splicing, capping, and polyadenylation before being exported into the cytosol.
Translational Control: Regulation during translation further influences final protein output.
Process of Transcription
Initiation of transcription is critical for gene expression control:
RNA polymerase II binds with transcription factors to form a pre-initiation complex at the promoter region.
Elements like TFIID, TAF, TFIIB, and TFIH regulate the assembly and stabilization of the transcription bubble to facilitate DNA unwinding and RNA synthesis.
Elongation and Termination of Transcription
During elongation, RNA polymerase II synthesizes RNA strands at a rapid pace (10-100 nucleotides/second) while ensuring fidelity through proofreading mechanisms.
Upon reaching the termination signals, RNA polymerase II is released, and the mRNA strand becomes processed for translation.
Cancer Biology and Pathway Dysregulation
Mutations in genes can lead to uncontrolled cell proliferation, characterizing cancer. Key categories of cancer-related genes include:
Oncogenes: Mutated proto-oncogenes that promote tumorigenesis.
Example: RAS mutations causing continuous proliferation pathways regardless of external signals.
Tumor Suppressor Genes: Loss-of-function mutations that result in the failure to control cell cycle checkpoints.
Example: p53 and retinoblastoma genes with roles in apoptosis and cell cycle regulation.
DNA Repair Genes: Defects in DNA repair pathways lead to increased genomic instability and cancer progression.
Hallmarks of Cancer
This concept outlines essential capabilities acquired during tumor development, including:
Sustaining proliferative signaling.
Evading growth suppressors.
Activating invasion and metastasis.
Enabling replicative immortality.
Inducing angiogenesis.
Resisting cell death.
Summary of Gene Regulation and Cancer Pathways
Understanding these signaling pathways and molecular mechanisms is fundamental in developing therapeutic strategies against cancers, highlighting ongoing research aimed at disrupting malformed signaling and restoring normal cellular functions.
Stem Cells Overview
Introduction to Stem Cells
This lecture aims to introduce the concepts of stem cells, their characteristics, classifications, and potential applications in medicine and research. A focus on ethical implications regarding stem cell sources is also emphasized.
Classification of Stem Cells
Embryonic Stem Cells: Derived from human or animal embryos with the ability to differentiate into all cell types.
Adult Stem Cells (Somatic Stem Cells): Found in tissues, capable of differentiating into specialized cells. Sources include blood, adipose tissue, and bone marrow.
Induced Pluripotent Stem Cells (iPSCs): Somatic cells chemically reprogrammed to assume pluripotent state, allowing them to differentiate into any cell type.
Characteristics of Stem Cells
Potency and differentiation capabilities define stem cell classes:
Totipotent: Can differentiate into any cell type of an organism, exemplified by zygote-derived cells.
Pluripotent: Able to differentiate into cells from all germ layers but not entire organisms.
Multipotent: Limited to differentiating into subsets of cells within a tissue.
Unipotent: Can only become one cell type, closely approaching terminal differentiation.
Applications of Stem Cells in Medicine and Research
Stem Cell Transplantation: Used in treatments for blood cancers (e.g., leukemia) where harvested stem cells can regenerate blood components post-chemotherapy.
Regenerative Medicine: Utilizing stem cells to restore damaged tissues, such as bone injuries, by integrating stem cells, scaffolds, and signaling pathways.
Disease Modeling: Using iPSCs derived from patients to study diseases like Marfan syndrome in a laboratory setting, aiding in drug development without directly using patient tissues.
Conclusion
These preliminary introductions to cancer signaling pathways and stem cell biology provide a foundational understanding critical for progressing into advanced topics on cancer pathways, therapeutic strategies, and stem cell applications in regenerative medicine. Further attention to ethical considerations remains paramount in all areas of stem cell research and application.